Peninsula Research Associates, Inc. | Rolling Hills Estates, CA

Research site

(Unclaimed)

Location

550 Deep Valley Drive, Suite 317, Rolling Hills Estates, California, United States of America

Site insights

Top conditions

Top treatments

LY3841136

LY3305677

LY3437943

Ritlecitinib

Retatrutide

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 14 total trials

A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2

The purpose of this study is to learn about the safety and effects of the study medicine ritlecitinib for the possible treatment of nonsegmental viti...

Enrolling

Stable Nonsegmental Vitiligo

Active Nonsegmental Vitiligo

Drug: Ritlecitinib

Drug: Placebo

A Chronic Weight Management Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

The purpose of this Phase-2 chronic weight management master protocol (CWMM) is to create a framework to evaluate the safety and efficacy of various...

Enrolling

Overweight

Obesity

Drug: Placebo

Drug: LY3841136

A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy

The overall aims of this study are to demonstrate that treatment with PVX108 immunotherapy has an acceptable safety profile and is effective for redu...

Invitation-only

Peanut Allergy

Peanut-Induced Anaphylaxis

Biological: Placebo

Biological: PVX-108

A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight

The main purpose of this study, performed under a master protocol W8M-MC-CWMM (NCT06143956), is to investigate weight management efficacy and safety...

Enrolling

Overweight and Obesity

Obesity

Drug: Placebo

Drug: LY3305677

A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight

The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to investigate weight management efficacy and safet...

Enrolling

Overweight and Obesity

Obesity

Drug: Placebo

Drug: LY3841136

A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

The main purpose of this study is to investigate the effect of retatrutide on renal function in participants with overweight or obesity and chronic k...

Enrolling

Overweight or Obesity

CKD

Drug: Placebo

Drug: Retatrutide

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

The purpose of this clinical trial is to learn about the safety, extent of the side effects, and immune responses of the study vaccine (called varian...

Enrolling

COVID-19

SARS-CoV-2 Virus

Biological: Variant-adapted BNT162b2 (Omicron XBB.1.5) 3 microgram dose

Biological: Variant-adapted BNT162b2 (Omicron XBB.1.5) 10 microgram dose

Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older

Brief Summary of Stage 1:The purpose Stage 1 (Phase I/IIa) is to assess the safety and immunogenicity of a single intramuscular (IM) injection of 3 d...

Active, not recruiting

Respiratory Syncytial Virus Immunization

Biological: RSV vaccine candidate formulation 2

Biological: RSV vaccine candiate formulation 1

Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate

The purpose of this study is to assess the safety and immunogenicity of a single intramuscular (IM) injection of different doses of an respiratory sy...

Enrolling

Healthy Volunteers

Human Metapneumovirus

Biological: RSV/hMPV vaccine candidate Dose B

Biological: RSV/hMPV vaccine candidate Dose A